How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Sell
40
IPHA Quote, Financials, Valuation and Earnings
Last price:
$1.74
Seasonality move
:
-1.43%
Day range:
$1.71 - $1.79
52-week range:
$1.63 - $2.63
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
22.34x
P/B ratio:
20.75x
Volume:
4.2K
Avg. volume:
20.1K
1-year change:
-11.28%
Market cap:
$162.1M
Revenue:
$13.7M
EPS (TTM):
-$0.60
Earnings Data
Next earnings date for IPHA
Mar 26
2026
Most recent earnings per share
--
Missed by --
(Feb 6/2026)
Consensus Estimate
--
(Feb 6/2026)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
IPHA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | $2.6M | -- | -- | -- | -- |
| 03/26/2026 | Q4 | $2.6M | -- | -- | -- | -- |
| 11/13/2025 | Q3 | $2.3M | -- | -- | -- | -- |
| 03/10/2020 | Q4 | -- | -- | -- | -$0.17 | -- |
| 11/13/2019 | Q3 | -- | -- | -- | $0.05 | -- |
Innate Pharma SA Earnings Questions
-
How Much did Innate Pharma SA Generate in Revenue Last Quarter?
Innate Pharma SA reported -- worth of top line sales in its most recent quarter.
-
Did Innate Pharma SA Beat Earnings Last Quarter?
Innate Pharma SA announced earnings per share of -- which represents a miss of analyst forecast a -- per share.
-
Is Innate Pharma SA Profitable?
Innate Pharma SA reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Innate Pharma SA EPS Next Year?
Innate Pharma SA's earnings are forecast to decrease from -$0.66 per share to -$0.64 per share next year representing a decrease of -2.35%.
-
When is Innate Pharma SA's Earnings Date?
Innate Pharma SA's next earnings date is March 26, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Sell
45
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
59
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 31x
Alerts
Buy
61
KELYB alert for Feb 6
Kelly Services, Inc. [KELYB] is up 243.2% over the past day.
Buy
86
PAHC alert for Feb 6
Phibro Animal Health Corp. [PAHC] is up 22% over the past day.
Sell
35
GDXU alert for Feb 6
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 19.48% over the past day.
